Post-translational modifications of Hsp90 and translating the chaperone code

SJ Backe, RA Sager, MR Woodford… - Journal of Biological …, 2020 - ASBMB
Cells have a remarkable ability to synthesize large amounts of protein in a very short period
of time. Under these conditions, many hydrophobic surfaces on proteins may be transiently …

Histone deacetylase inhibitors in cancer therapy

AA Lane, BA Chabner - Journal of clinical oncology, 2009 - ascopubs.org
Purpose Epigenetic processes are implicated in cancer causation and progression. The
acetylation status of histones regulates access of transcription factors to DNA and influences …

Collateral sensitivity of natural products in drug-resistant cancer cells

T Efferth, MEM Saeed, O Kadioglu, EJ Seo… - Biotechnology …, 2020 - Elsevier
Cancer chemotherapy is frequently hampered by drug resistance. Concepts to combine
anticancer drugs with different modes of action to avoid the development of resistance did …

Dual role of heat shock proteins as regulators of apoptosis and innate immunity

AL Joly, G Wettstein, G Mignot, F Ghiringhelli… - Journal of innate …, 2010 - karger.com
Stress or heat shock proteins (HSPs) 70 and 90 are powerful chaperones whose expression
is induced in response to a wide variety of physiological and environmental insults. These …

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

J Tan, S Cang, Y Ma, RL Petrillo, D Liu - Journal of hematology & oncology, 2010 - Springer
Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and
activities of transcriptional factors involved in both cancer initiation and progression through …

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against …

W Fiskus, Y Wang, A Sreekumar… - Blood, The Journal …, 2009 - ashpublications.org
The polycomb repressive complex (PRC) 2 contains 3 core proteins, EZH2, SUZ12, and
EED, in which the SET (suppressor of variegation–enhancer of zeste-trithorax) domain of …

Is resistance useless? Multidrug resistance and collateral sensitivity

MD Hall, MD Handley, MM Gottesman - Trends in pharmacological …, 2009 - cell.com
When cancer cells develop resistance to chemotherapeutics, it is frequently conferred by the
ATP-dependent efflux pump P-glycoprotein (MDR1, P-gp, ABCB1). P-gp can efflux a wide …

P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells

R Li, R Wu, L Zhao, M Wu, L Yang, H Zou - ACS nano, 2010 - ACS Publications
Multidrug resistance (MDR), which is related to cancer chemotherapy, tumor stem cells, and
tumor metastasis, is a huge obstacle for the effective cancer therapy. One of the underlying …

Isoform-specific histone deacetylase inhibitors: the next step?

S Balasubramanian, E Verner, JJ Buggy - Cancer letters, 2009 - Elsevier
Histone deacetylases (HDACs) have emerged as attractive drug targets, particularly for
neoplastic indications. This large family is divided into four classes, of which three consist of …

Autophagy inhibition enhances vorinostat‐induced apoptosis via ubiquitinated protein accumulation

JS Carew, EC Medina, JA Esquivel II… - Journal of cellular …, 2010 - Wiley Online Library
Autophagy is an evolutionarily conserved cell survival pathway that enables cells to recoup
ATP and other critical biosynthetic molecules during nutrient deprivation or exposure to …